Stocktoria
Outset Medical, Inc. OM
Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2020-09-15
Outset Medical, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $119.5M | $113.7M | $130.4M | $115.4M | $102.6M |
| Gross profit | $46.8M | $38.6M | $29.0M | $17.8M | $7.6M |
| R&D expense | $21.2M | $38.4M | $57.3M | $48.9M | $36.7M |
| Operating income | -$66.7M | -$113.4M | -$169.8M | -$161.0M | -$130.5M |
| Interest expense | $14.0M | $23.9M | $12.7M | $3.6M | $1.7M |
| Income tax | $718,000 | $491,000 | $523,000 | $295,000 | $199,000 |
| Net income | -$81.7M | -$128.0M | -$172.8M | -$163.0M | -$131.9M |
| EPS (diluted) | $-5.37 | $-36.96 | $-52.28 | $-3.38 | $-2.89 |
| Operating cash flow | -$46.3M | -$116.3M | -$131.4M | -$145.7M | -$130.3M |
| Free cash flow | -$47.1M | -$117.2M | -$134.8M | -$154.1M | -$133.4M |
| Cash & equivalents | $35.0M | $124.0M | $68.5M | $73.2M | $182.3M |
| Inventory | $47.6M | $59.4M | $49.2M | $51.5M | $39.2M |
| Total assets | $264.5M | $275.8M | $313.8M | $400.1M | $463.5M |
| Total liabilities | $137.5M | $249.0M | $190.9M | $154.1M | $89.4M |
| Shareholders' equity | $127.0M | $26.8M | $122.9M | $246.0M | $374.1M |
Source: SEC EDGAR filings · CIK 0001484612 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.